The outlook for the equity markets is essentially binary from today’s perspective. Emotional knee-jerk market reactions in both directions can be expected in the near term. The medium to long-term outlook hinges on the change process under way in international value chains, as well as on the further developments in bond yields. Geographically, the effects will differ: while Europe confronts heightened challenges on the cost side, the US will have to deal with yield developments and their influence on the still lofty fundamental valuations of many shares.
In terms of equities and corporate bonds, the picture for individual business sectors sizes up as follows:
Energy: The surge in natural gas and crude oil prices is generating higher operating cash flows, even as the shift in sourcing creates added revenue potential especially for companies with spare capacity.
Basic materials: Prices for industrial metals, but also minerals, will remain at high levels. Changes in means of delivery and temporary shortages should result in positive special effects, but the offsetting factor in the medium to long run will be the increased risks associated with the environmental pollutants from mining and refining operations.
Automotive: Worldwide, the automotive industry is struggling with supply problems on the part of semiconductor manufacturers. Although the companies have this situation relatively well under control, the shortage of palladium (required for catalytic converters) and the production stoppage of certain components (e.g. wiring harnesses) are now causing additional headwinds. The shares of European carmakers are already trading at historically low fundamental valuations, so downside risks exist above all for US and Asian automotive companies.
Industrial: Heavy industry is suffering above all from today’s higher energy prices, which put a huge strain on production and logistics. However, the companies’ order books are already brim-full due to the Green Transformation. And now, the anticipated increase in defence spending could trigger a boom, especially in the machinery segment.
Banks: Russia’s war of attrition against Ukraine is also taking a toll on companies that have just come away with a whole skin from the pandemic. Today’s added burdens are causing financial stress and thus increase the risk of mounting loan defaults. In addition, bank shares tend to consolidate in phases of a flattening yield curve. It follows that the H1 2022 outlook for banks is neutral to slightly negative.
Healthcare: It is frequently the case that pharmaceutical and healthcare companies enjoy pricing power; hence, they should be in a position to outperform the overall market at least in relative terms. What’s more, many European pharmaceutical companies are attractively valued.
Market phases like the one we are currently witnessing can actually be opportune for medium- to long-term investors, at least from a stock-picking standpoint. Although we have opted to take a cautious approach to asset allocation by underweighting equities for the time being, we recommend that investors with a certain appetite for risk pay special attention to those companies with a solid market position and hefty pricing power. Also, their indebtedness relative to future operating income should be at a manageable level so that interest rate increases do not put a strain on the bottom line.
Companies like these have less of a problem passing on higher input costs and are rather in a position to maintain their profit margins in the face of slower sales growth rates and rising operating costs. Add to this the fact that companies with a dominant market position, unique selling proposition and relatively inelastic demand for their products tend to demonstrate greater stability in an inflationary environment.
Add the first comment